Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions

Breast Cancer Research and Treatment

Volumn 109, Issue 1, 2008, Pages 27-34

  Jeronimo, Carmen ^a,b   Monteiro, Paula ^a   Henrique, Rui ^a,c   Dinis Ribeiro, Mário ^a,d   Costa, Isabel ^a   Costa, Vera L ^a   Filipe, Luísa ^a   Carvalho, André L ^e   Hoque, Mohammad O ^e   Pais, Irene ^a   Leal, Conceição ^a   Teixeira, Manuel R ^a,c   Sidransky, David ^e  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d University of Porto   (Portugal)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer biomarkers; Epigenetic profile; Fine needle aspiration biopsy; Quantitative methylation specific PCR

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST LESION; CANCER DIAGNOSIS; CELL STRUCTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE LOCUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PROMOTER REGIONS (GENETICS); SULFITES; TUMOR MARKERS, BIOLOGICAL;

EID: 42149087728     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9620-x     Document Type: Article

References (45)

1. Sidransky D (2002) Emerging molecular markers of cancer. Nat Rev Cancer 2:210-219
2. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
3. Rountree MR, Bachman KE, Herman JG et al (2001) DNA methylation, chromatin inheritance, and cancer. Oncogene 20:3156-3165
4. Esteller M, Corn PG, Baylin SB, Herman JG et al (2001) A gene hypermethylation profile of human cancer. Cancer Res 61:3225-3229
5. Graff JR, Herman JG, Lapidus RG et al (1995) E-Cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res 55:5195-5199
6. Nass SJ, Herman JG, Gabrielson E et al (2000) Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. Cancer Res 60:4346-4348
7. Esteller M, Silva JM, Dominguez G et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564-569
8. Widschwendter M, Berger J, Hermann M et al (2000) Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J Natl Cancer Inst 92:826-832
9. Ferguson AT, Evron E, Umbricht CB et al (2000) High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci U S A 97:6049-6054
10. Umbricht CB, Evron E, Gabrielson E et al (2001) Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 20:3348-3353
11. Evron E, Umbricht CB, Korz D et al (2001) Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res 61:2782-2787
12. Dammann R, Yang G, Pfeifer GP (2001) Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 61:3105-3109
13. Fackler MJ, McVeigh M, Evron E et al (2003) DNA methylation of RASSF1A, HIN1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma. Int J Cancer 107:970-975
14. Jerónimo C, Costa I, Martins MC et al (2003) Detection of gene promoter hypermethylation in fine needle washings from breast lesions. Clin Cancer Res 9:3413-3417
15. Mehrotra J, Vali M, McVeigh M et al (2004) Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung. Clin Cancer Res 10:3104-3109
16. Lehmann U, Langer F, Feist H et al (2002) Quantitative assessment of promoter hypermethylation during breast cancer development. Am J Pathol 160:605-612
17. Globocan available from URL: http://www-dep.iarc.fr/
18. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106-130
19. Hamill J, Campbell ID, Mayall F et al (2002) Improved breast cytology results with near patient FNA diagnosis. Acta Cytol 46(1):19-24
20. Evron E, Dooley WC, Umbricht CB et al (2001) Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR. Lancet 357(9265):1335-1336
21. Pu RT, Laitala LE, Alli PM et al (2003) Methylation profiling of benign and malignant breast lesions and its application to cytopathology. Mod Pathol 16(11):1095-1101
22. Fackler MJ, McVeigh M, Mehrotra J et al (2004) Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64(13):4442-4452
23. Fackler MJ, Malone K, Zhang Z et al (2006) Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid. Clin Cancer Res 12(11 Pt 1):3306-3310
24. Page DL, Anderson TJ, Sakamoto G (1987) Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill-Livingstone, Edinburgh, p 193
25. Elston CW, Ellis IO (1998) Assessment of histological grade. In: Elston CW, Ellis IO (eds) The breast. Churchill-Livingstone, Edinburgh, p 365
26. Greene FL, Page DL, Fleming ID et al (2002) Breast. In: Greene FL, Page DL, Fleming ID et al (eds) AJCC cancer staging manual, 6th edn. Springer, New York, p 221
27. Cairns P, Esteller M, Herman JG et al (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7(9):2727-2730
28. Olek A, Oswald J, Walter JA (1996) A modified and improved method of bisulfite based cytosine methylation analysis. Nucleic Acids Res 24:5064-5066
29. Jerónimo C, Henrique R, Hoque MO et al (2004) Quantitative RARβ2 hypermethylation: a promising prostate cancer marker. Clin Cancer Res 10:4010-4014
30. Eads CA, Lord RV, Kurumboor SK et al (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60:5021-5026
31. Jerónimo C, Usadel H, Henrique R et al (2001) Quantitation of GSTP1 hypermethylation distinguishes between non-neoplastic prostatic tissue and organ confined prostate adenocarcinoma. J Natl Cancer Inst 93:1747-1752
32. Jeronimo C, Henrique R, Hoque MO et al (2004) A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 10:8472-8478
33. Tokumaru Y, Nomoto S, Jerónimo C et al (2003) Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene 22:6954-6958
34. Henrique R, Jerónimo C, Hoque MO et al (2005) Frequent 14-3-3σ promoter methylation in benign and malignant prostate lesions. DNA Cell Biol 24:264-269
35. Henrique R, Jeronimo C, Hoque MO et al (2005) MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev 14(5):1274-1278
36. Rosenbaum E, Hoque MO, Cohen Y et al (2005) Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clin Cancer Res 11(23):8321-8325
37. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054
38. Lehmann U, Celikkaya G, Hasemeier B et al (2002) Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Cancer Res 62:6634-6638
39. Lewis CM, Cler LR, Bu DW et al (2005) Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 11:166-172
40. Eads CA, Danenberg KD, Kawakami K et al (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28(8):E32
41. Issa JP, Ottaviano YL, Celano P et al (1994) Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 7:536-540
42. Waki T, Tamura G, Sato M et al (2003) Age-related methylation of tumor suppressor and tumour-related genes: an analysis of autopsy samples. Oncogene 22:4128-4133
43. Jin Z, Tamura G, Tsuchiya T et al (2001) Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 85:69-73
44. Hoque MO, Feng Q, Toure P et al (2006) Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J Clin Oncol 24(26):4262-4269
45. Muller HM, Widschwendter A, Fiegl H et al (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63:7641-7645